• ÆäÀ̽ººÏ °øÀ¯
  • Æ®À§ÅÍ °øÀ¯
  • ¹ÌÅõµ¥ÀÌ °øÀ¯
  • URLº¹»ç
  • ´õº¸±â
  • °ü½ÉÀÇ·áÁø µî·Ï

±è¼±ºó

±è¼±ºó

±è¼±ºó ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
°¨¿°³»°ú
¿ÀÈÄ
- -
¿ÀÈÄ
- - °¨¿°Áúȯ (°¨¿°Áúȯ,¸²ÇÁÀýŬ¸®´Ð,¿­º´Å¬¸®´Ð)

±è¼±ºó ±³¼öÀÇ »ó¼¼Á¤º¸

ÇзÂ

more
  • 2013 .03  ~  2018 .08  :  ¿¬¼¼´ëÇб³ Àǰú´ëÇÐ ¹Ú»ç
  • 2009 .09  ~  2012 .08  :  ¿¬¼¼´ëÇб³ Àǰú´ëÇÐ ¼®»ç
  • 2000 .03  ~  2007 .02  :  ÇѸ²´ëÇб³ Àǰú´ëÇÐ Çлç

°æ·Â

more
  • 2017 .09  ~   :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø °¨¿°³»°ú ÀÓ»ó Á¶±³¼ö
  • 2017 .03  ~  2017 .08  :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø °¨¿°³»°ú ÀÓ»ó Á¶±³¼ö ´ë¿ì
  • 2016 .03  ~  2017 .02  :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø ³»°úÇÐ ±³½Ç ÀÓ»ó Ãʺù ±³¼ö
  • 2015 .03  ~  2016 .02  :  Ä«Å縯´ëÇб³ ¼­¿ï¼º¸ðº´¿ø °¨¿°³»°ú ÀÓ»ó °­»ç (ÀÌ½Ä °¨¿°)
  • 2014 .10  ~   :  °¨¿°³»°ú ºÐ°úÀü¹®ÀÇ
  • 2013 .03  ~  2014 .08  :  ¿¬¼¼´ëÇб³ ½ÅÃ̼¼ºê¶õ½º º´¿ø °¨¿°³»°ú ÀÓ»ó ¿¬±¸ Á¶±³¼ö
  • 2012 .03  ~  2013 .02  :  ¿¬¼¼´ëÇб³ ½ÅÃ̼¼ºê¶õ½º º´¿ø °¨¿°³»°ú ÀÓ»ó °­»ç
  • 2012 .03  ~   :  ³»°ú Àü¹®ÀÇ
  • 2008 .03  ~  2012 .02  :  ¿¬¼¼´ëÇб³ ½ÅÃ̼¼ºê¶õ½º º´¿ø ³»°ú Àü°øÀÇ
  • 2007 .03  ~  2008 .02  :  ¿¬¼¼´ëÇб³ ½ÅÃ̼¼ºê¶õ½º º´¿ø ÀÎÅÏ

¼ö»ó³»¿ª

more
  • 2013 .05  :  ¿ì¼ö ¿¬Á¦»ó (´ëÇÑ È­Çпä¹ýÇÐȸ)

ÇÐȸȰµ¿

more
  •  ~   :  ´ëÇÑ °¨¿°ÇÐȸ ȸ¿ø
  •  ~   :  ´ëÇÑ È­Çпä¹ýÇÐȸ ȸ¿ø
  •  ~   :  ´ëÇÑ ³»°úÇÐȸ ȸ¿ø
  •  ~   :  ´ëÇÑ Á¶Ç÷¸ð¼¼Æ÷ À̽ÄÇÐȸ ȸ¿ø

³í¹®

more
  • [±¹¿Ü³í¹®] (Clinical features of re-emerging hepatitis A: an analysis of patients hospitalized during an urban epidemic in Korea)
  • [±¹¿Ü³í¹®] (Clinical features and outcomes of acute kidney injury among patients with acute hepatitis A)
  • [±¹¿Ü³í¹®] (Low plasma levels of the soluble receptor for advanced glycation end products in HIV-infected patients with subclinical carotid atherosclerosis receiving combined antiretroviral therapy)
  • [±¹¿Ü³í¹®] (Diagnostic value of the serum galactomannan assay for invasive aspergillosis: it is less useful in non-haematological patients)
  • [±¹¿Ü³í¹®] (Short communication: factors influencing time to CD4(+) T cell counts >200 cells/mm(3) in HIV-infected individuals with CD4(+) T cell <50 cells/mm(3) at the time of starting combination antiretroviral therapy)
  • [±¹¿Ü³í¹®] (Red blood cell distribution width is an independent predictor of mortality in patients with gram-negative bacteremia)
  • [±¹¿Ü³í¹®] (Effects of tuberculosis on the kinetics of CD4(+) T cell count among HIV-infected patients who initiated antiretroviral therapy early after tuberculosis treatment)
  • [±¹¿Ü³í¹®] (Trend of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in an institution with a high rate of MRSA after the reinforcement of antibiotic stewardship and hand hygiene)
  • [±¹¿Ü³í¹®] (Simulation of pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infection in Seoul, South Korea)
  • [±¹¿Ü³í¹®] (Plasma klotho levels were inversely associated with subclinical carotid atherosclerosis in HIV-infected patients receiving combined antiretroviral therapy)
  • [±¹¿Ü³í¹®] (HIV antiretroviral resistance mutations among antiretroviral treatment-naive and -experienced patients in South Korea)
  • [±¹¿Ü³í¹®] (A comparison of the predicted risk for cardiovascular disease between HIV-infected and uninfected persons in Korea)
  • [±¹¿Ü³í¹®] (Risk factors for 28-day mortality in elderly patients with extended-spectrum ¥â-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia)
  • [±¹¿Ü³í¹®] (Pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infection in Seoul, South Korea)
  • [±¹¿Ü³í¹®] (Incidence and risk factors for carbapenem- and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipients)
  • [±¹¿Ü³í¹®] (Mathematical modeling of HIV prevention measures including pre-exposure prophylaxis on HIV incidence in South Korea)
  • [±¹¿Ü³í¹®] (Short communication: prospective comparison of qualitative versus quantitative polymerase chain reaction for monitoring virologic treatment failure in HIV-infected patients)
  • [±¹¿Ü³í¹®] (Risk factors for the acquisition of carbapenem-resistant Escherichia coli at a tertiary care center in South Korea: a matched case-control study)
  • [±¹¿Ü³í¹®] (Risk factors for mortality in patients with Serratia marcescens bacteremia)
  • [±¹¿Ü³í¹®] (The C-Reactive Protein/Albumin Ratio as an Independent Predictor of Mortality in Patients with Severe Sepsis or Septic Shock Treated with Early Goal-Directed Therapy)
  • [±¹¿Ü³í¹®] (Utility of the Montreal Cognitive Assessment (MoCA) and its subset in HIV-associated neurocognitive disorder (HAND) screening)
  • [±¹¿Ü³í¹®] (Breakthrough invasive fungal diseases during voriconazole treatment for aspergillosis: A 5-year retrospective cohort study)
  • [±¹¿Ü³í¹®] (Long Pentraxin 3 as a Predictive Marker of Mortality in Severe Septic Patients Who Received Successful Early Goal-Directed Therapy)
  • [±¹³»³í¹®] (Reply: Vitamin C as a Possible Therapy for COVID-19.)
  • [±¹³»³í¹®] (Interim Guidelines on Antiviral Therapy for COVID-19)

Àú¼­

more
  • ±¹³» À¯ÀÔ°¡´É ÇØ¿Ü °¨¿°º´ ½Å±Ô °ü¸®Áöħ

ÃÖÁ¾¼öÁ¤ÀÏ : 2018.08.21